Walder Wyss advised collana IT GmbH on the deal. Collana it GmbH has acquired Data Dynamic AG based in Berne. Data Dynamic AG is a leading...
Collana IT’s Acquisition of Data Dynamic AG
Mökah AG’s Acquisition of H. Jakober AG
Walder Wyss advised Mökah AG on the transaction. Mökah AG, a company of the Kanalservice Group and portfolio company of Ufenau Capital Partners, acquired H. Jakober AG as...
Cimeio Therapeutics’ $50 Million Series A Financing Round
Walder Wyss advised Versant Ventures on the deal. VISCHER advised Cimeo Therapeutics. Versant Ventures announced the debut of Cimeio Therapeutics, a biotechnology company developing a novel...
GarLa Group’s Acquisition of Enz Group AG
Walder Wyss advised GarLa Group, a portfolio company of Ufenau Capital Partners, on the transaction. GarLa Group acquired Enz Group AG based in Giswil OW. Enz Group...
LORIOT’s Series A Financing Round
Walder Wyss advised LORIOT on the deal. LORIOT announced the closing of the Series A Financing Round with WIKA Group as investor. LORIOT is a global...
Collana IT’s Acquisition of Neolution
Walder Wyss advised collana IT GmbH on the deal. collana it GmbH has acquired all the shares in the Swiss Neolution Ltd based in Pfaeffikon SZ....
Kooky’s €6 Million Financing Round
Bär & Karrer advised kooky in this transaction. Walder Wyss advises UVC Partners. The start-up kooky has completed financing round of over six million Euro. In...
Otto Group’s Acquisition of Majority Stake in Medgate Group
Walder Wyss advised Medgate on the deal. CMS and Bratschi advised the Otto Group. Berner Fleck Wettich advised founders and shareholders of BetterDoc. The Otto Group,...
Otto Group’s Acquisition of Majority Stake in Medgate Group
IN BRIEF: CMS Hasche Sigle, Walder Wyss Ltd., advised on the matter. CMS Hasche Sigle advised Otto Group GmbH with a team including Malte Grtzmacher (Commercial...
Veristat’s Acquisition of SFL Group
Walder Wyss has advised the two former shareholders, Shayesteh Fürst-Ladani und Walter Fürst, on the deal. Niederer Kraft Frey advised Veristat. The two former shareholders, Shayesteh...
J. Safra Sarasin’s Acquisition of Remaining 42.5% Shares in Zweiplus
Walder Wyss advised Bank J. Safra Sarasin AG in the transaction. Bank J. Safra Sarasin AG acquired the remaining 42.5% of the Swiss online bank zweiplus ag...
Memo Therapeutics’ CHF 37 Million Series B Financing Round
Walder Wyss advised Adjuvant Capital. Memo Therapeutics AG, an innovator in the field of antibody discovery and development, announced the close of an oversubscribed Series B...